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Objectives: Endovascular repair (EVAR) of ruptured abdominal aortic aneurysms (rAAA) has been shown to acutely
decrease procedural mortality compared to open aortic repair (OAR). However, little is known about the effect of
choice of procedure; EVAR vs OAR, or the impact of physician and institution volume on long-term survival and
outcome.
Methods: Patients hospitalized with rAAA who underwent either OAR or EVAR, were derived from the Medicare
inpatient dataset (1995-2004) using ICD9 codes. We evaluated long-term survival after OAR and EVAR in the entire
fee-for-service Medicare population, and then in patients matched by propensity score to create two similar cohorts for
comparison with Kaplan-Meier analysis. Annual surgeon and hospital volumes of EVAR (elective and ruptured), OAR
(elective and ruptured), and rAAA (EVAR and OAR) were divided into quintiles to determine if increasing volumes
correlate with decreasing mortality. Predictors of survival were determined by Cox modeling.
Results: A total of 43,033 Medicare beneficiaries had rAAA repair: 41,969 had OAR and 1,064 had EVAR. The
proportions of patients with diabetes, hypertension, cardiovascular, cerebrovascular, renal disease, hyperlipidemia, and
cancer were statistically higher in the EVAR than in the OAR group, whereas lower extremity vascular disease was higher
in the OAR group. The initial evaluation of EVAR vs OAR, prior to propensity matching, showed no statistical advantage
in EVAR-survival after 90 days. The survival analysis of patients matched by propensity score showed a benefit of EVAR
over OAR that persisted throughout the 4 years of follow-up (P  .0042). Perioperative and long-term survival after
rAAA repair correlated with increasing annual surgeon and hospital volume in OAR and EVAR and also with rAAA
experience. EVAR repair had a protective effect (HR  0.857, P  .0061) on long-term survival controlling for
comorbidities, demographics, and hospital and surgeon volume.
Conclusion: When EVAR and OAR patients are compared using a reliable statistical technique such as propensity analysis,
the perioperative survival advantage of rAAA repaired endovascularly is maintained over the long term. Institutional
experience with rAAA is critical for survival after either OAR or EVAR. ( J Vasc Surg 2008;48:1092-1100.)Surgical repair of the ruptured abdominal aortic aneu-
rysm (rAAA) has a perioperative mortality rate up to 70
percent,1 resulting in one of the highest surgical mortalities
of all vascular emergencies. Between 1960 through 2000,
meta-analysis has shown a gradual, albeit modest, reduc-
tion in mortality of 3.5 percent per decade, which is most
likely the result of advances in medical care and surgical
technique.2 Identifying factors contributing to this reduc-
tion may help to further reduce the mortality associated
with repair of rAAA, especially in centers with high mortal-
ity rates.
In the past decade, the magnitude and invasiveness of
surgical interventions has been dramatically changed by the
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1092advent of minimally-invasive procedures. Multiple publica-
tions have compared the short-term mortality of the open
rAAA procedure to rAAA repaired endovascularly3-5 and
have found differences similar to those reported contrasting
EVAR to the elective open approach.6-9 The lower hemo-
dynamic shifts associated with endovascular repairs
(EVAR) of AAA could potentially benefit survival after
rAAA, especially in those patients that are already hemody-
namically unstable. In fact, the reported short-term benefit
of aortic ruptures repaired endovascularly when compared
to open aortic repair (OAR) may be partially attributed to
the different surgical approaches: femoral access vs midline
laparotomy with complete aortic cross clamp, which con-
fers different hemodynamic and physiologic challenges.
However, there are explanations beyond the operative ap-
proaches that must be considered when comparing the
outcomes of endovascular and open repair of rAAA. One of
the most challenging obstacles in evaluating this patient
population is the disparate nature of their presentation and
the variations of their clinical comorbidities. We used pro-
pensity matching to standardize the EVAR and OAR co-
horts. However, despite the use of propensity analysis,
there still exist limitations in the analysis of administrative
datasets. These limitations include certain variables, such as
the time from arrival at the emergency room to aneurysm
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ologic data are not captured and, therefore, cannot be
controlled.
Improvements in surgical outcomes with increased sur-
geon and hospital volume have been observed in elective
vascular procedures10-14 and many other surgical interven-
tions, such as coronary artery bypass surgeries.15-17 How-
ever, a national volume-outcome analysis for rAAA has not
been performed and the long-term effectiveness of endo-
vascular repair of rAAA is unknown.
To describe the relationships between surgical tech-
nique, volume, and long-term rAAA mortality, we exam-
ined the Medicare database for the years 1995-2004.
METHODS
Data sources and study population. Medicare In-
patient Standard Analytical file (Medicare part A) from
1995-2004was obtained from the Center forMedicare and
Medicaid Services through Research Data Assistance Cen-
ter (resdac@umn.edu). The file contains hospital-
discharge abstracts on 100%Medicare reimbursed hospital-
izations, except those delivered to beneficiaries enrolled in
Medicare HMOs (approximately 10% patients). The data
was supplemented with Medicare Denominator file which
contain demographic, geographic, and vital status data on
all Medicare beneficiaries.
Patients who underwent rAAA repair were identified
through a combination of rAAA diagnoses (ICD-9-CM
code 441.3 – aortic abdominal aneurysm, ruptured; any
position) with primary or any secondary ICD-9-CM pro-
cedure codes for EVAR and OAR (Table I). All cases that
had diagnoses of 441.1 thoracic aneurysm, ruptured or
441.6 thoracoabdominal aneurysm, ruptured were ex-
cluded from the analysis. The designated ICD-9 procedure
code for EVAR was created in the year 2000, and only
patients with this specific endovascular code were included
in the EVAR cohort.
We assessed the following comorbidities (primary and
all secondary diagnosis): cardiac (coronary artery and val-
Table I. ICD9 Diagnostic and procedural codes for
population selection
Code Description
Diagnostic
441.3 Aortic abdominal aneurysm, ruptured
Procedural
39.71 Endovascular implantation of graft in
abdominal aorta
38.44 Resection of abdominal aorta with replacement
39.25 Aorta-iliac-femoral bypass
39.52 Other repair of aneurysm
38.34 Resection of abdominal aorta with anastomosis
38.64 Other excision of abdominal aorta
38.40 Resection of vessel with replacement,
unspecified site
38.60 Other excision of vessels, unspecified sitevular disease, congestive heart failure, and arrhythmia),diabetes, hypertension, chronic pulmonary, clinically sig-
nificant lower extremity vascular disease, cerebrovascular,
liver disease, renal atherosclerosis, renal failure, kidney
transplant, neurological disorders, cancer, rheumatoid ar-
thritis, and disorder of lipid metabolism. The list of ICD9
diagnosis codes for co-morbidities is provided in Table II,
online only. The lack of “present on admission” flag in the
Medicare dataset creates a challenge in the separation of
comorbidities from complications. We identified as comor-
bidities the chronic conditions reported at the index hospi-
talization (hospitalization when rAAA repair occurred) and
all comorbidities that were already present in the patient’s
previous hospitalizations.
Statistics. Kaplan-Meier analysis was used to analyze
survival. Differences between groups were compared with
the log-rank test. Mortality from all causes was included in
the analysis. If a patient had several rAAA repairs, only the
first surgery was included in the survival analysis. Cox
proportional hazard regression was used to estimate
covariate-adjusted hazard ratio of long-term survival. The
following variables were included in the model: baseline
co-morbidities, demographics, hospital and surgeon vol-
ume characteristics, and year when the surgery was per-
formed. The final model included variables with a signifi-
cance level of 0.05 or less. We used theMartingale methods
to check the proportional hazard assumption.
To assess annual hospital and physician experience with
AAA, all repairs (elective and ruptured) were included in
the volume calculation. Hospital and surgeon volume were
expressed as number of EVAR (ruptured and elective),
OAR (ruptured and elective), or rAAA procedures (rup-
tured EVAR and ruptured OAR) for each year. In addition,
we also created 5 categories (quintiles) for volume based on
equal size groups. The number of surgeons who performed
one rAAA procedure per year was disproportionally higher
than the number of surgeons with higher annual volumes.
Therefore, for the rAAA volume, the first and second
quintiles that included surgeons with 1 annual rAAA repair
were combined. Volumes were included as continuous
variables in Cox models.
To estimate the difference in baseline patients’ charac-
teristics, univariate analyses were conducted using Student
t tests for continuous variables and 2 or the Fisher exact
test, where it was appropriate, for dichotomous variables.
The Cochran-Armitage test was used to analyze trends in
the utilization of EVAR for rAAA by hospitals and sur-
geons.
Treatment selection bias was controlled by construct-
ing propensity score.18 All baseline variables including age,
gender, race, co-morbidities, year of surgery, the hospital,
and surgeon volume in EVAR, OAR, and rAAA were
included in the logistic regression model to predict proba-
bility that a patient would receive EVAR vs OAR. The fit of
the propensity model to the data was assessed using the
concordance index.19 Patients who underwent EVAR were
matched to patients who had OAR, using individual pro-
pensity scores. We used 1:1 matching scheme without
replacement.20 Additional testing was performed to ensure
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and co-morbid characteristics between matched groups.
Paired t test was used for continuous and McNemar’s test
for categorical variables. Survival distributions for matched
patients were compared using Kaplan-Meier curves and the
log-rank test. Cox proportional hazard regression was used
to identify risk factors of survival.
Statistical significance was expressed as both P values
and 95% confidence intervals (CI). P values less than .05
were considered statistically significant. All statistical anal-
ysis was performed using the SAS system software version
9.1 (SAS Institute Inc, Cary, NC).
RESULTS
Study population. From 1995 through 2004,
43,760 Medicare beneficiaries were identified who had
repair of rAAA. Among them, 727 patients (1.66% of the
cohort) were electively admitted with diagnoses of aortic
abdominal aneurysm without mention of rupture and had
rAAA diagnoses on their discharge summary. These pa-
tients were excluded from the study. The reason for exclu-
sion was that these patients could have had interoperative
rupture during elective repair. The final dataset contained
43,033 patients: 41,969 had open AAA repair and 1,064
had an endovascular procedure. We found 75 patients who
had both endovascular and open repair during the same
hospitalization. Seventy patients had the two procedures
Table III. Base-line characteristics of the patients who ha
aneurysm repair
Characteristic
Endo AA
(n  1
Age (years) 76.96
Female gender (%) 25.8
White race (%) 91.3
Black race (%) 6.3
Asian race (%) 0.6
Native American race (%) 0.0
Hispanic ethnicity (%) 0.7
Comorbidities (%)
Diabetes 11.7
Hypertension 57.3
Chronic pulmonary 40.2
Coronary 35.2
Congestive heart failure 23.2
Cardiac arrhythmia 32.8
Valvular diseases 7.8
Clinically significant lower extremity 4.4
Renal atherosclerosis 2.6
Vascular intestine disease 0.6
Kidney transplant 0.5
Renal failure 9.2
Cerebrovascular 9.0
Other neurological 5.3
Liver diseases 1.1
Hyperlipidemia 17.0
Cancer 6.2
Rheumatoid arthritis 2.7
 Plus-minus values are: means  95% confidence interval.during the same day, while the remaining 5 patients firsthad EVARwith subsequent open repair within the next 1-5
days. Perioperative mortality for these patients was 44%
(95% CI, 33.65-55.94%) and median survival 108 days. It
appeared from the records that these patients had under-
gone an original attempt at EVARwhich was not successful
then requiring an open operation. These 75 patients were
considered as failed EVAR and, therefore, included in the
EVAR group. Patients treated with EVAR and OAR were
different with regard to base-line characteristics (Table III).
The EVAR group included slightly older patients (77 vs 76
years of age), more females (25.8% vs 22.9%), and a greater
number of African American patients (6.7% vs 3.9%). The
proportion of patients with diabetes, hypertension, cardiac
arrhythmia, coronary artery, valvular, vascular intestine,
cerebrovascular disease, renal atherosclerosis, renal failure,
renal transplant, rheumatoid arthritis, hyperlipidemia, and
cancer were statistically higher in the EVAR than in the
OAR group. Despite significant variability in the comor-
bidities, only clinically significant lower extremity vascular
diseases was more prevalent in the OAR group (6.10% vs
4.42%, P  .0233) as shown by Table III. To control for
patient, hospital, and surgeon characteristics, a propensity
model was developed and OAR and EVAR patients were
matched by their propensity score. A total of 1,044 pairs
were identified. The final propensity score model yielded
excellent discriminative characteristics (concordance
index 0.892). Patients in these cohorts were similar in all
n or endovascular ruptured aortic abdominal
oup Open AAA group
P value) (n  41,969)
5 75.9  0.07 .0001
22.87% .0228
93.68% .0021
3.86% .0001
0.47% .3839
0.12% .8295
0.51% .2824
8.43% .0001
45.16% .0001
37.51% .0705
27.53% .0001
21.64% .2176
28.91% .0057
5.28% .0002
6.10% .0233
0.66% .0001
0.24% .0164
0.10% .0009
6.45% .0003
6.04% .0001
5.00% .6069
1.27% .6774
8.46% .0001
4.25% .0019
1.83% .0324d ope
A gr
,064
 0.4
4%
5%
9%
6%
9%
5%
5%
3%
2%
4%
1%
0%
9%
2%
3%
6%
6%
1%
2%
6%
2%
1%
0%
3%variables (Table IV, online only).
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rAAA increased over the study period – from 222 patients
(5% of rAAA repairs) in 2001, and to 289 patients (9% of
rAAA repairs) in 2004 (Fig 1, A). The number of hospitals
as well as number of surgeons using EVAR for rAAA rose
consistently during this time period (from 174 to 224 or
12-17% hospitals and from 204 to 263 surgeons or 7-11%)
(Fig 1, B and C). Trends in number of surgeons, hospitals,
and EVAR procedures were statistically significant.
Mortality. Kaplan-Meier analysis of 1,044 pairs of
matched patients, showed a survival benefit of EVAR over
OAR, which persisted over 4 years of follow-up (log-rank
P  .0042) (Fig 2). The median survival was 137 days in
EVAR and 35 days in the OAR group. Prior to matching,
Fig 1. Percent of patients with ruptured aortic abdominal aneu-
rysms repaired endovascularly (A), percent of surgeons using en-
dovascular procedures for ruptured aortic abdominal aneurysm
repair (B), and percent of hospitals using endovascular repair for
ruptured aortic abdominal aneurysm (C) from 2001-2004.
P values of trends shown in the parenthesis.
Fig 2. Kaplan-Meier analysis of survival of patients treated with
endovascular (EVAR) and open (OAR) repair of ruptured aortic
abdominal aneurysm. Cases were matched by patients baseline
demographic (age, gender and race), comorbidities, annual hospi-
tal and surgeon volume and year of surgery using propensity score
analysis.including all 43,033 patients in the dataset, Kaplan-Meieranalysis showed a statistically significant short-term benefit
of EVAR vs OAR that persisted for only 90 days of follow-
up, and an insignificant difference in long-term survival
after 90 days and throughout the 4-year follow-up period
(log-rank P  .2007).
The year the surgery was performed did not affect
survival after OAR; however, we did observe an improve-
ment in survival after EVAR with advancing years. Long-
term survival after OAR and EVAR were the same in
2001-2002 (P  .8296), however in 2003-2004 the sur-
vival difference was statistically significant favoring EVAR
(P  .0279).
Effect of volume on mortality. Perioperative mortal-
ity decreased with increasing surgeon experience for both
procedures (Fig 3). For very low-volume surgeons, there
Fig 3. Thirty-day mortality after ruptured aortic abdominal an-
eurysm surgery in relation to annual surgeon volume of aortic
abdominal aneurysm repair by quintiles: A, open (ruptured and
elective), B, endovascular (ruptured and elective), or C, ruptured
(open and endovascular). *P.05 for volume quintiles vs the first
quintile.was no significant difference in EVAR or open mortality
nal aneurysm repair (open and endovascular) by quintiles.
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mortality rates between very low- and very high-volume
surgeons was more substantial for EVAR, therefore, high-
volume endovascular surgeons had lower operative mortal-
ity than high-volume open surgeons (28.37% vs 37.72%,
P  .05) (Fig 3, A and B). High-volume endovascular
surgeons had lower mortality when compared to high-
volume open surgeons (28.37% vs 37.72%, P  .05) 30
days after rAAA repair. Perioperative survival significantly
improved with surgeon rAAA volume: a 10% decline in
30-day mortality was observed with increasing annual vol-
ume from 1 to 3 or more rAAA procedures (Fig 3, C).
Moreover, long-term survival also improved with increas-
ing surgeon’s experience in OAR (Fig 4, A), EVAR (Fig 4,
B), and rAAA (Fig 4, C). The survival advantage persisted
to the end of the follow-up period.
A similar analysis was performed focusing on annual
hospital volume (Figs 5 and 6). Ruptured AAAs repaired in
very low-volume hospitals (first quintile) had similar peri-
operative mortality rates for both open and endovascular
procedures (56.42% vs 57.67%, P  .05), whereas there
was a significant difference at the highest volume hospitals
(fifth quintile) favoring EVAR: 38.43% after OAR vs
30.37% after EVAR (P .05) (Fig 5,A and B). In addition,
mortality declined from 53% to 40% with increasing annual
hospital volume of rAAA repair from 1 to 7 or more
procedures, respectively (Fig 5, C). Long-term survival
improved with increasing hospital annual volume in OAR
(Fig 6, A), EVAR (Fig 6, B), and rAAA volume (Fig 6, C).
Predictors of mortality. Risk factors for decreased
long-term survival after endovascular repair of rAAA iden-
tified with Cox model included: cerebrovascular disease,
female gender, and patient age at the time of surgery.
Hospital volume in rAAA and patient’s hyperlipidemia had
a protective effect on likelihood of survival (Table V). These
two factors also had a protective effect on survival after
open repair of rAAA (up to 10 years). Additional protective
factors for OAR were hospital and surgeon volumes and
hypertension. Multiple risk factors that negatively affected
the survival after open rAAA included kidney transplant,
chronic liver disease, renal failure, cancer, cerebrovascular,
neurological, coronary, chronic pulmonary disease, renal
atherosclerosis, diabetes, rheumatoid arthritis, female gen-
der, patient age at the time of procedure, and white race
(Table V).
After controlling for baseline characteristics, predictors
of long-term survival included: EVAR (Hazard ratio
[HR]  0.857, P  .0061), hospital annual volume in
rAAA surgeries (HR  0.971, P  .0002). Risk factors
found to decrease the likelihood of survival were cerebro-
vascular disease (HR  1.543, P  .0001) and patient age
at the time of surgery (HR  1.037, P  .0001) as a
continuous variable (Table VI).
DISCUSSION
In endovascular repair of ruptured aortic aneurysms,
laparotomy, aortic cross-clamping, and retroperitoneal dis-
section is avoided thereby reducing hemodynamic shifts asFig 4. Kaplan-Meier survival analysis after ruptured aortic ab-
dominal aneurysm surgery by surgeon volume. A - survival after
open repair of ruptured abdominal aortic aneurysm in relation to
annual surgeon volume of open aortic abdominal aneurysm repair
(ruptured and elective) by quintiles. B - survival after endovascular
repair of ruptured abdominal aortic aneurysm in relation to annual
performing surgeon volume of endovascular aortic abdominal
aneurysm repair (ruptured and elective) by quintiles. C - survival
after repair of ruptured abdominal aortic aneurysm in relation
to annual performing surgeon volume of ruptured aortic abdomi-
endovascular) by quintiles.
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nificantly decreased mortality of endovascularly repaired
rAAA at 30 days vs OAR have been demonstrated in three
prospective trials.21-23 In one prospective multicenter
study, no significant difference was noted in 30-day mor-
tality between endovascular and open repairs (35% vs 39%,
P  .78).24 As acknowledged by the authors, this result
may be due to a larger percentage of sicker and hemody-
namic unstable patients treated endovascularly. Also a sin-
gle center study in which hemodynamically unstable pa-
tients had been excluded (31% vs 31% P .98) reported no
survival improvement after endovascular repair vs open
repair.25 However, in this study there were differences in
case mix among the patients treated with different proce-
dures and there was no attempt to perform a propensity
matching analysis to control for comorbidities. In fact,
Fig 5. Thirty-day mortality after ruptured aortic abdominal an-
eurysm surgery in relation to annual hospital volume of aortic
abdominal aneurysm repair by quintiles: A, open (ruptured and
elective), B, endovascular (ruptured and elective), or C, ruptured
(open and endovascular). *P.05 for volume quintiles vs the first
quintile.more patients treated endovascularly (50%) than patientFig 6. Kaplan-Meier survival analysis after ruptured aortic ab-
dominal aneurysm surgery by hospital volume. A, survival after
open repair of ruptured abdominal aortic aneurysm in relation to
annual hospital volume of open aortic abdominal aneurysm repair
(ruptured and elective) by quintiles. B, survival after endovascular
repair of ruptured abdominal aortic aneurysm in relation to annual
hospital volume of endovascular aortic abdominal aneurysm repair
(ruptured and elective) by quintiles. C, survival after repair of
ruptured abdominal aortic aneurysm in relation to annual hospital
volume of ruptured aortic abdominal aneurysm repair (open and
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risk for cardiac complications.
Review of our data shows that hypertension and hyper-
lipidemia are protective against death following EVAR.
This seems counterintuitive since these factors are felt to
predispose patients to the development of atherosclerosis.
A possible explanation for this effect, which has been ob-
Table V. Hazard ratios and 95% confidence intervals for C
abdominal aortic aneurysms, hazard ratio 1 is protective,
Predictor Hazar
Endovascular repair (n  1,064)
Cerebrovascular 1.6
Female gender 1.2
Patient age at time of surgery** 1.0
Ruptured AAA hospital annual volume* 0.9
Hyperlipidemia 0.7
Open repair (n  41,969)
Kidney transplant 1.8
Liver diseases 1.3
Renal failure 1.3
Cancer 1.2
Cerebrovascular 1.2
Other neurological 1.1
Female gender 1.1
Renal atherosclerosis 1.1
Coronary 1.1
Diabetes 1.1
Rheumatoid arthritis 1.1
White race 1.0
Patient age at time of surgery 1.0
Chronic pulmonary 1.0
OAAA annual hospital volume* 0.9
Ruptured AAA hospital annual volume* 0.9
OAAA annual surgeon volume* 0.9
Congestive heart failure 0.9
Hypertension 0.8
Hyperlipidemia 0.7
*per one additional surgery.
**per one additional calendar year.
Table VI. Risk factors of death after ruptured abdominal
aortic aneurysms repair for patients matched by
propensity score (n  2,088), hazard ratio 1 is
protective, hazard ratio 1 is harmful, hazard ratio  1
is indifferent
Predictor
Hazard
ratio
95% Confidence
interval P value
Endovascular repair 0.857 0.768-0.957 .0061
Ruptured AAA hospital
annual volume* 0.971 0.957-0.986 .0002
Patient age at the time
of surgery** 1.037 1.029-1.045 .0001
Cerebrovascular
diseases 1.543 1.299-1.833 .0001
Hyperlipidemia 0.736 0.627-0.865 .0002
Hypertension 0.888 0.792-0.995 .0415
*per one additional surgery.
**per one additional calendar yearserved by other investigators, is that the medications usedto treat these patients, such as beta-blockers and statins,
may have a cardiovascular protective effect and once diag-
nosed and treated may decrease the instance of fatal myo-
cardial events.26,27
Hemodynamic determinants, such as blood pressure or
cardiac output, are not variables in the Medicare dataset
and, therefore, cannot be included in this analysis. More-
over, the Medicare database includes medical information
on most US residents over the age of 65, but this does not
ensure equal distribution of risk factors within its popula-
tion. These are intrinsic problems when using large datasets
that are not prospectively randomized. The use of propen-
sity scores confers the advantage of having a single estimate
available to control for multiple differences between groups
in a matched-pair analytical design in order to create two
similar cohorts for comparison.
We initially performed an analysis of all 43,033 pa-
tients. The unmatched survival analysis of the Medicare
dataset showed a significant reduction in mortality for
EVAR which disappeared at 90 days. Although these re-
sults, as well as those previously described, implied that
rAAA repaired endovascularly benefited from improved
short-term survival, it appeared that this advantage was not
sustained. There was no statistical difference between the
unmatched survival curves for EVAR and OAR, and an
eventual higher death rate for rAAA patients selected to
nalysis for open and endovascular repair of ruptured
rd ratio 1 is harmful, hazard ratio  1 is indifferent
o 95% Confidence interval P value
1.263-2.103 .0002
1.065-1.507 .0075
1.019-1.041 .0001
0.950-0.995 .0166
0.614-0.959 .0200
1.275-2.582 .0009
1.263-1.526 .0001
1.325-1.448 .0001
1.179-1.310 .0001
1.167-1.279 .0001
1.128-1.245 .0001
1.145-1.208 .0001
1.014-1.329 .0312
1.084-1.142 .0001
1.065-1.155 .0001
1.017-1.196 .0183
1.034-1.137 .0008
1.040-1.043 .0001
1.002-1.050 .0365
0.998-0.999 .0001
0.987-0.996 .0002
0.988-0.991 .0001
0.916-0.967 .0001
0.877-0.921 .0001
0.744-0.817 .0001ox a
haza
d rati
30
67
30
72
67
14
88
85
43
22
85
76
61
12
09
03
84
41
25
99
91
90
41
99
80have EVAR was demonstrated.
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tions in that many factors that contribute to the morbidity
and mortality of patients are not captured within the Medi-
care data. These factors include the hemodynamic stability
of the patient at presentation (except emergent vs elective),
duration of time from presentation to intervention within
the same day, size, and location of the aneurysm, and
aneurysm neck diameter and configuration. Recent studies
have also shown that more unstable patients may in fact be
offered endovascular repair preferentially to open repair in
some centers.24 To further support this premise, in our
study, patients that underwent EVAR had more comor-
bidities than those patients undergoing OAR (Table III).
In order to further investigate the impact of these
factors, baseline characteristics of each group (endo vs
open) were examined, hypothesizing that endovascular
patients were likely sicker preoperatively and perhaps at
greater risk of dying from disease unrelated to their rAAA.
The endovascular cohort was comprised of significantly
more females, was older, and had significantly higher rates
of comorbidities compared to the open cohort (Table III).
To control for the population differences, propensity score
analysis was employed.
Repeated survival analysis of EVAR and OAR patients,
matched by propensity score, demonstrated that the early
survival benefit of EVAR is actually sustained throughout
the 4 year follow-up period (Fig 2). Recently reported
comparison of long-term survival after elective AAA re-
paired by EVAR or OAR showed that initial advantage of
endovascular procedure disappear over time and survival
curves crossed even after matching patients by propensity
score.28 The explanation for this convergence is speculative
and could relate to the possibility that patients who were
previously felt to be too high-risk for OAR are now being
treated with EVAR. These patients may have succumbed to
an early mortality within several years of EVAR, not be-
cause of AAA-related complications, but rather due to their
comorbidities.
The significant improvement in survival of rAAA re-
paired endovascularly in 2003-2004 may be due to a better
distribution and variety of endovascular devices available, as
well as greater surgeon experience. The learning curve
associated with elective EVAR is vital and necessary to
achieve optimal results29-31 including the repair of a rup-
tured AAA. In fact, survival rates for endovascular rAAA
repairs improved with increased surgeon volume of EVAR
procedures (elective and ruptured) (Fig 4, B). These find-
ings were replicated for surgeon volume of OAR (elective
and rupture) (Fig 4,A). Each additional OARwas found to
be progressively protective in Cox analysis (Table V). These
results suggest that increased surgeon exposure to AAAs
improves technical skills and fosters better emergent clinical
decisions when faced with a ruptured aortic aneurysm.
Successful management of a ruptured aortic aneurysm
is dependent on many factors that are outside the surgeon’s
hands. The mobilization of the vascular team and surgical
staff must be rapid and proficient, and immediate availabil-
ity of CT resources is critical; increased experience withrAAA pre- and postoperative care will undoubtedly im-
prove survival. The findings of increased survival of rAAA
with increased total hospital rAAA volume (Fig 6, C)
supports the hypothesis that high institutional experience
improves management of the most treacherous vascular
emergency from the emergency room to the ICU and
ultimately results in better outcomes. These hospital vol-
ume-outcome improvements have been observed in elec-
tive vascular procedures10-14 and statewide analyses of rup-
tured AAA repairs,4 as well as coronary artery bypass,
pancreatic cancer, and hip replacement surgeries.15-17 Cox
analysis shows that each additional open repair per hospital
(elective and rupture) was protective for rAAA repaired
traditionally (Table V). While broadening experience and
the constant progress of stent technology will certainly
lead to a widespread adoption of the endovascular approach
for the treatment of rAAA, the feasibility of EVAR in the
context of this surgical emergency currently remains lim-
ited by adverse anatomy, severe hemodynamic instability,
and device unavailability.22 The use of OAR of rAAA
cannot be abandoned due to the limitations in interven-
tional skill as well as many patients’ aortic anatomy is
unsuitable for current EVAR grafts.
Improved survival from rAAA, with high hospital and
surgeon volumes, may lead to the conclusion that we
should move towards regionalization and centers of excel-
lence in order to decrease the mortality rate of repaired
rAAA. This should be considered in those patients that are
stable for transfer if the center is not accustomed to man-
aging complex vascular emergencies or there is not an
experienced surgeon available at the time of presentation.
Unfortunately, a ruptured aneurysm is rarely diagnosed in
the field, and only diagnosed at the time of presentation to
the hospital. Indeed, the better outcomes of high-volume
hospitals can also arise as the result of selective referral of
hemodynamically stable patients to these hospitals. Al-
though we were able to track patient information longitu-
dinally, the Medicare dataset is subject to certain limita-
tions. Missing from this database is information on
patients’ preoperative hemodynamics and vascular anat-
omy. Although diagnoses of comorbidities are reported,
Medicare data does not capture the extent or severity of a
disease; ejection fractions or creatinine levels are, unfortu-
nately, unavailable. We cannot determine whether these
unmeasured characteristics account for significant differ-
ences between the two cohorts of patients treated with
OAR and EVAR. Although the list of potential confound-
ers we used for propensity score matching was extensive,
selection bias related to characteristics such as hemody-
namic instability, aneurysm size, availability of endovascular
imaging and inventory, which are not reported in the
Medicare dataset, cannot be ruled out.
In conclusion, this study shows an increased survival
after rAAA of patients who were treated with EVAR as
compared to those treated with OAR over the course of 4
years. However institutional and surgeon experience were
essential to fully benefit from the use of this procedure for
the treatment of rAAA.
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Comorbidity ICD9 code
Index hospitalization
Congestive heart failure 398.91, 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.91, 404.13, 404.93, 425.4, 425.5,
425.7, 425.8, 425.9, 428.0, 428.1, 428.20, 428.22, 428.30, 428.32, 428.40, 428.42, 428.9
Cardiac arrhythmia 426.0, 426.10, 426.11, 426.12, 426.13, 426.7, 426.9, 427.0, 427.1, 427.2, 427.3, 427.9, V45.0,
V53.3
Valvular disease 093.2, 394, 395, 396, 397, 424, V42.2, V43.3
Coronary disease 412, 413, 414, 429.2
Diabetes 250
Hypertension 401, 402, 403, 404, 405
Pulmonary diseases 416, 417.9, 490, 491, 492, 493, 494, 495.0, 495.1, 495.2, 495.3, 495.4, 495.5, 495.6, 495.8,
495.9, 496, 500, 501, 502, 503, 504, 505, 506.0, 506.2, 506.4, 506.9, 508.1, 508.8, 508.9
Clinically significant lower
extremity vascular diseases
440.22, 440.23, 440.24, 440.3, 444.22, V43.4
Renal atherosclerosis 440.1
Vascular intestine disease 557.1
Renal failure 403.01, 403.11, 403.91, 404.02, 404.03, 404.12, 404.13, 404.92, 404.93, 585, 588.0, V45.1,
V56.0, V56.1, V56.2, V56.3, V56.8
Other renal diseases 582, 583.0, 583.1, 583.2, 583.4
Kidney transplant V420
Liver disease 070.22, 070.23, 070.32, 070.33, 070.44, 070.54, 070.9, 456.0, 456.1, 571, 572.1, 572.2, 572.3,
572.4, 572.8, 573.0, 573.1, 573.8, 573.9
Cerebrovascular diseases and
paralysis
342, 344.1, 344.3, 344.4, 344.5, 344.9, 437.0, 438
Other neurological diseases 330, 331, 332, 333, 334.0, 334.1, 334.2, 334.4, 334.8, 335.0, 335.1, 335.2, 335.8, 335.9,
336.0, 336.2, 343, 344.0, 348.1, 348.3, 344.2, 344.6, 345, 437.3, 437.4, 437.5, 437.6, 437.7
Hyperlipidemia 272
Cancer 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158,
159, 160, 161, 162, 163, 164, 165, 170, 171, 172, 174, 175, 176, 179, 180, 181, 182, 183,
184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201,
202, 203.0, 238.6
Rheumatoid arthritis 446, 701.0, 710.0, 710.1, 710.2, 710.3, 710.4, 710.8, 710.9, 711.2, 719.3, 714, 720, 725,
728.5, 728.89
Pre-index hospitalizations
History of heart failure 398.91, 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.91, 404.13, 404.93, 425.4, 425.5,
425.7, 425.8, 425.9, 428
Cardiac arrhythmia 426, 427.0, 427.1, 427.2, 427.3, 427.4, 427.5, 785.0, 996.01, 996.04, V45.0, V53.3
Valvular disease 093.2, 394, 395, 396, 397, 424, V42.2, V43.3
Coronary disease 410, 412, 413, 414, 429.2
Pulmonary 415, 416, 417, 490, 491, 492, 493, 494, 495, 496, 500, 501, 502, 503, 504, 505, 506.0, 506.2,
506.4, 506.9, 508
Clinically significant lower
extremity vascular diseases
440.22, 440.23, 440.24, 440.3, 444.22, 996.7, V43.4
Renal atherosclerosis 440.1, 445.81
Vascular intestine disease 557.1, 557.9
Hypertension 401, 402, 403, 404, 405, 458.0, 458.1, 458.8, 458.9
Hyperlipidemia 272
Cerebrovascular diseases and
paralysis
342, 344.1, 344.3, 344.4, 344.5, 344.9, 362.30, 362.31, 362.34, 433, 434, 435, 436, 437.8,
437.9, 438, 784.3
Other neurological diseases 330, 331, 332, 333, 334.0, 334.1, 334.2, 334.3, 334.4, 334.8, 334.9, 336.0, 335.0, 335.1,
335.2, 335.8, 335.9, 336.0, 336.2, 340, 343, 344.0, 344.2, 344.6, 345, 348.1, 348.3, 430,
431, 432, 437.3, 437.4, 437.5, 437.6, 437.7, 780.3
Diabetes 250
Renal failure V45.1, V56.0, V56.1, V56.2, V56.3, V56.8, 403.01, 403.11, 403.91, 404.02, 404.03, 404.12,
404.13, 404.92, 404.93, 585, 586, 588.0
Renal diseases 582, 583.0, 583.1, 583.2, 583.4, 583.6, 583.7
Liver disease 070.22, 070.23, 070.32, 070.33, 070.44, 070.54, 070.6, 070.9, 456.0, 456.1, 456.2, 571, 572.2,
572.3, 572.4, 572.8, 573
Cancer 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158,
159, 160, 161, 162, 163, 164, 165, 170, 171,172, 174, 175, 176, 179, 180, 181, 182, 183,
184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201,
202, 203.0, 238.6
Kidney transplant V42.0
Rheumatoid arthritis 446, 701.0, 710.0, 710.1, 710.2, 710.3, 710.4, 710.8, 710.9, 711.2, 719.3, 714, 720, 725,728.5, 728.89, 729.30
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abdominal aneurysm, hospital’s and surgeon’s annual volume in AAA repair after matching by propensity score
Characteristic
Endo AAA group
(n  1,044)
Open AAA group
(n  1,044) P value
Patients
Age (years) 76.93 76.99 .8462
Female gender (%) 26.15% 26.34% .9203
White race (%) 91.57% 92.53% .4263
Comorbidities (%)
Diabetes 11.59% 10.92% .6299
Hypertension 57.37% 56.23% .6008
Chronic pulmonary 39.94% 39.94% 1
Coronary 34.86% 36.78% .3573
Congestive heart failure 22.99% 24.04% .5741
Cardiac arrhythmia 32.76% 33.72% .6467
Valvular diseases 7.66% 6.51% .3035
Clinically significant lower extremity 4.50% 6.23% .0747
Renal atherosclerosis 2.20% 2.49% .6682
Vascular intestine disease 0.67% 0.77% .7963
Kidney transplant 0.57% 0.49% .763
Renal failure 9.20% 7.76% .2457
Cerebrovascular 9.10% 10.63% .2482
Other neurological 5.46% 5.94% .6381
Liver diseases 1.15% 1.44% .5637
Hyperlipidemia 17.05% 17.72% .6846
Cancer 6.23% 6.80% .5775
Rheumatoid arthritis 2.59% 2.87% .6911
Annual Volume
Hospital volume in endo AAA repair 23 23 .6553
Hospital volume in open AAA repair 25 26 .8118
Surgeon volume in endo AAA repair 8 7 .0001
Surgeon volume in open AAA repair 6 6 .9062
